Comparative 12-week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real-world multicenter retrospective study.

Georgakopoulos, J R; Lam, K; Sandhu, V K; Ighani, A; Phung, M; Piguet, V; Yeung, J

Georgakopoulos, J R; Lam, K; Sandhu, V K; Ighani, A; Phung, M; Piguet, V; Yeung, J.

Afiliación

Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Lam K; Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Sandhu VK; Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Ighani A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Phung M; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Piguet V; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Yeung J; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.

J Eur Acad Dermatol Venereol ; 34(8): e416-e418, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32176394

Asunto(s)

Fármacos Dermatológicos; Psoriasis; Anticuerpos Monoclonales Humanizados; Factores Biológicos; Fármacos Dermatológicos/efectos adversos; Humanos; Psoriasis/tratamiento farmacológico; Estudios Retrospectivos; Índice de Severidad de la Enfermedad; Resultado del Tratamiento; Ustekinumab/efectos adversos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google